These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15649255)

  • 1. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation.
    Tsuda H; Morita D; Kimura M; Shinto E; Ohtsuka Y; Matsubara O; Inazawa J; Tamaki K; Mochizuki H; Tamai S; Hiraide H
    Cancer Sci; 2005 Jan; 96(1):48-53. PubMed ID: 15649255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features.
    Tsuda H; Tani Y; Weisenberger J; Kitada S; Hasegawa T; Murata T; Tamai S; Hirohashi S; Matsubara O; Natori T
    Cancer Sci; 2005 Jun; 96(6):333-9. PubMed ID: 15958055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
    Dabbs DJ; Chivukula M; Carter G; Bhargava R
    Mod Pathol; 2006 Nov; 19(11):1506-11. PubMed ID: 16941011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma.
    Sawada M; Tsuda H; Kimura M; Okamoto S; Kita T; Kasamatsu T; Yamada T; Kikuchi Y; Honjo H; Matsubara O
    Cancer Sci; 2003 Nov; 94(11):986-91. PubMed ID: 14611676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women.
    Nalwoga H; Arnes JB; Wabinga H; Akslen LA
    APMIS; 2008 Jun; 116(6):515-25. PubMed ID: 18754326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones.
    Tsuda H; Takarabe T; Hasegawa T; Murata T; Hirohashi S
    Hum Pathol; 1999 Oct; 30(10):1134-9. PubMed ID: 10534158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation.
    Shien T; Tashiro T; Omatsu M; Masuda T; Furuta K; Sato N; Akashi-Tanaka S; Uehara M; Iwamoto E; Kinoshita T; Fukutomi T; Tsuda H; Hasegawa T
    J Clin Pathol; 2005 Dec; 58(12):1299-304. PubMed ID: 16311351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.
    Brower ST; Ahmed S; Tartter PI; Bleiweiss I; Amberson JB
    Ann Surg Oncol; 1995 Sep; 2(5):440-4. PubMed ID: 7496840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-erbB3 protein in primary breast carcinomas.
    Naidu R; Yadav M; Nair S; Kutty MK
    Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Expression of Caspase1 and Epidermal Growth Factor Receptor in Invasive Breast Carcinoma and Their Biological and Prognostic Associations.
    Enan ET; Abd El Hafez A; Hussin E; Hany HSEDI
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2529-2537. PubMed ID: 39068588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer.
    Umekita Y; Ohi Y; Souda M; Rai Y; Sagara Y; Sagara Y; Tamada S; Tanimoto A
    Diagn Pathol; 2011 Apr; 6():36. PubMed ID: 21496280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?
    Korsching E; Packeisen J; Liedtke C; Hungermann D; Wülfing P; van Diest PJ; Brandt B; Boecker W; Buerger H
    J Pathol; 2005 Aug; 206(4):451-7. PubMed ID: 15906273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases.
    Tsuda H; Takarabe T; Hasegawa F; Fukutomi T; Hirohashi S
    Am J Surg Pathol; 2000 Feb; 24(2):197-202. PubMed ID: 10680887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
    Bryan BB; Schnitt SJ; Collins LC
    Mod Pathol; 2006 May; 19(5):617-21. PubMed ID: 16528377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.
    Castellano I; Marchiò C; Tomatis M; Ponti A; Casella D; Bianchi S; Vezzosi V; Arisio R; Pietribiasi F; Frigerio A; Mano MP; Ricardi U; Allia E; Accortanzo V; Durando A; Bussolati G; Tot T; Sapino A
    Mod Pathol; 2010 Feb; 23(2):260-9. PubMed ID: 19915523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions.
    Tsuda H; Hirohashi S
    Pathol Int; 1998 Jul; 48(7):518-25. PubMed ID: 9701014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
    Kashiwagi S; Yashiro M; Takashima T; Aomatsu N; Kawajiri H; Ogawa Y; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
    Br J Surg; 2013 Mar; 100(4):490-6. PubMed ID: 23319435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-3 protein expression in ductal carcinoma in situ of the breast.
    Bobrow LG; Millis RR; Happerfield LC; Gullick WJ
    Eur J Cancer; 1997 Oct; 33(11):1846-50. PubMed ID: 9470844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.